期刊文献+

YB-1蛋白对白血病细胞K562/A02生物学行为的影响

Influence of YB-1 Protein on the Biological Behaviour in K562/A02 Cells
下载PDF
导出
摘要 本研究探讨YB-1基因表达下调后对白血病细胞K562/A02生物学行为的影响及其机制。采用脂质体介导的方法将已构建的人YB-1基因特异性shRNA及随机片段HK的真核表达载体转染进白血病细胞K562/A02中,RT-PCR和免疫印迹反应检测YB-1 mRNA和蛋白表达量的改变;采用MTT法和细胞周期测定分析对白血病细胞增殖的影响;用AnnexinⅤ检测白血病细胞的凋亡程度;采用MTT法检测细胞IC50值变化;RT-PCR和流式细胞术检测基因转染前后细胞中的MDR1 mRNA和P-gp表达的变化。结果表明,阳性转染的3组细胞YB-1基因和蛋白的表达量明显低于随机片段组和未转染细胞;生长曲线提示阳性转染组细胞生长缓慢,细胞周期动力学分析显示阳性转染组G1期细胞增多,G2期与S期细胞显著减少;在小剂量As2O3作用下,阳性转染组细胞的凋亡数量明显高于对照组细胞;阳性转染细胞的阿霉素IC50明显低于随机片段组和阴性对照组;阳性转染细胞MDR1 mRNA水平明显降低,P-gp的峰值较对照组明显左移。结论:YB-1特异性shRNA能有效降低白血病细胞中YB-1的表达,减慢细胞生长,增加白血病细胞对化疗药物的敏感性,加速细胞凋亡。 The aim of this study was to investigate whether the growth,apoptosis and sensitivity to anticancer agent could be altered after introduction of YB-1 shRNA eukaryotic expression vector into the K562/A02 cells,and its possible molecular mechanisms.The recombinant eukaryotic expression plasmids including YB-1 shRNA and the vector-random-sequence were introduced into K562/A02 cells by lipofectamine mediation,and the positive clones were screened by G418.RT-PCR and Western blot were employed to detect the expression of mRNA and protein of YB-1 in leukemia cells,respectively.The proliferative ability of the cells was determined by MTT assay and cell cycle analysis.Apoptosis of K562/A02 cells was assayed by AnnexinⅤ-FITC/PI double labeled flow cytometry.The drug sensitivity to anticancer agent was determined by MTT assay.The expressions of MDR1 gene and P-gp were detected by RT-PCR and flow cytometry respectively.The results indicated that the levels of mRNA and protein of YB-1 decreased dramatically in three groups of positively transfected cells when compared with control cells.The inhibitory rates of 3 different shRNA sequences targeting YB-1 gene were(65.1±2.1)%,(27.4±1.3)% and(67.4±1.6)% respectively.The introduction of exogenous YB-1 shRNA gene into K562/A02 cells resulted in decreased levels of the proliferative ability in K562/A02 cells,and displayed higher at G1,lower at G2 and S phase in cell cycle distribution in comparison with the control groups.AnnexinⅤ/PI detection indicated higher AnnexinⅤ+ ratio in 3 groups of positively transfected cells after being treated with As2O3 of 0.5 μmol/L for 24 hours.The IC50 values of doxorubicin in 3 groups of positively transfected cells were significantly lower than that in control group.The level of MDR1 gene and P-gp decreased significantly in 3 groups of positively transfected cells.It is concluded that the transfection with YB-1 shRNA gene can inhibit the proliferation of leukemia cells and induce cell apoptosis.The expression of MDR1 mRNA and P-gp decrease after transfection of YB-1 shRNA into K562/A02 cells.
出处 《中国实验血液学杂志》 CAS CSCD 2011年第2期342-347,共6页 Journal of Experimental Hematology
基金 国家自然科学基金资助项目(编号81070423) 江苏省卫生重大项目(编号K2005017) 江苏省医学重点人才资助项目(编号RC2007034)
关键词 YB-1蛋白 白血病细胞 细胞增殖 细胞凋亡 YB-1 protein K562/A02 cell cell proliferation cell apoptosis
  • 相关文献

参考文献11

  • 1Rafletseder U, Frye B, Rauen T, et al. Splicing factor SRp30c interaction with Y-box protein-1 confers nuclear YB-1 shuttling and alternative splice site selection. J Biol Chem, 2003 ; 278 ( 20 ) : 18241 - 18248.
  • 2Bader AG, Vot PK. Inhibition of protein synthesis by Y box- binding protein 1 blocks oncogenic cell transformation. Mol Cell Biol, 2005; 25(6): 2095-2106.
  • 3周磊磊,许文林,秦茹娟,唐华容,沈慧玲.Y-盒结合蛋白1短发夹环RNA真核表达载体的构建[J].江苏大学学报(医学版),2007,17(1):35-37. 被引量:2
  • 4Skabkin MA, Kiselyova OI, Chemov KG, et al. Structural organization of mRNA complexes with major core mRNP protein YB-1. Nucleic Acids Res, 2004 ;32(18) : 5621 -5635.
  • 5Terry G, Ho L, Londesborough P, et al. The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions. Br J Cancer, 2007 ;96( 1 ) : 110 - 117.
  • 6Yoshimatsu T, Uramoto H, Oyama T, et al. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer. Anticancer Res, 2005, 25(5): 3437-3443.
  • 7Jurchott K, Bergmarm S, Stein U, et al. YB-1 as a cell cycleregulated transcription factor facilitating cyclin A and cyclin B1 gene expression. J Biol Chem, 2003; 278(30) : 27988 -27996.
  • 8Hu Q, Bhattacharya C, Maity SN. CCAAT binding factor (CBF) binding mediates cell cycle activation of topoisomerase Ha. J Biol Chem, 2002; 277(40) : 37191 -37200.
  • 9Hu Z, Jin S, Scotto KW, et al. Transcriptional activation of the MDR1 gene by UV irradiation. J Biol Chem, 2000; 275(4) : 2979 - 2985.
  • 10Shibahara K, Sugio K, Osaki T, et al. Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-smaU cell lung cancer. Clin Cancer Res, 2001 ; 7(10) : 3151 -3155.

二级参考文献9

  • 1Yu JY, DeBuiter SL, Turner DL. BNA interference by expression of short-interfering BNAs and hairpin BNAs inmammalian cells[J]. Proc Nail Acad Sci USA, 2002,99(9) : 6047 -6051.
  • 2Fromm MF. The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans [ J ].Adv Drug Deliv Rev, 2002, 18(10) :1295 -1310.
  • 3Huang J, Tan PH, Li KB, et al. Y-box binding protein,YB-1, as a marker of tumor aggressiveness and response to adjuvant chemotherapy in breast cancer[J]. Int J Oncol, 2005, 26(3):607-613.
  • 4Didier DK, Schiffenhauer J, Woulfe SL, et al. Characterization of the eDNA encoding a protein binding to the major histo-eompatability complex class Ⅱ Y box [ J ].Proc Nail Acad Sci USA, 1988, 85:7322-7326.
  • 5Fujita T, Ito K, Izumi H, et al. Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel [ J ]. Clinical Cancer Res, 2005, 11 (24) : 8837 - 8844.
  • 6Ute R, Bjom F, Thomas R, et al. Splicing factor SRp30c interaction with Y-box protein-1 coders nuclear YB-1 shuttling and alternative splice site selection [ J ]. J Biol Chem, 2003, 278 (20) : 18241 - 18248.
  • 7Annette L, Stephanie M, Traey H, et al. The Y-boxbinding protein, YBI, is a potential negative regulator of the p53 tumor suppressor [ J ]. J Biol Chem, 2003,278 ( 37 ) :35516 - 35523.
  • 8Bader AG, Vot PK. Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation[J]. Mol Cell Biol, 2005, 25(6) :2095 -2106.
  • 9Miyagishi M, Taira K. U6 promoter-driven siRNAs with four uridine 3 overhangs efficiently suppress targeted gene expression in mammalian cells[J]. Nat Biotechnol, 2002, 20(5):497-500.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部